Sarrafzadegan N - Search Results

1

Awareness, treatment and control of hypertension, dyslipidaemia and diabetes mellitus in an Iranian population: the IHHP study.

Shirani S, Kelishadi R, Sarrafzadegan N, Khosravi A, Sadri G, Amani A, Heidari S, Ramezani MA. Shirani S, et al. Among authors: sarrafzadegan n. East Mediterr Health J. 2009 Nov-Dec;15(6):1455-63. East Mediterr Health J. 2009. PMID: 20218138 Free article.

2

Evaluation of the Quit and Win contest for smoking cessation in the Islamic Republic of Iran.

Shahrokhi S, Kelishadi R, Sarrafzadegan N, Khosravi A, Roohafza HR, Pooya A, Mollabashi R. Shahrokhi S, et al. Among authors: sarrafzadegan n. East Mediterr Health J. 2008 Nov-Dec;14(6):1270-9. East Mediterr Health J. 2008. PMID: 19161102 Free article.

3

The metabolic syndrome in hypertensive and normotensive subjects: the Isfahan Healthy Heart Programme.

Kelishadi R, Derakhshan R, Sabet B, Sarraf-Zadegan N, Kahbazi M, Sadri GH, Tavasoli AA, Heidari S, Khosravi A, Amani A, Tolouei HR, Bahonar A, Rezaei AA, Ashtiani, Moatarian A. Kelishadi R, et al. Ann Acad Med Singap. 2005 Apr;34(3):243-9. Ann Acad Med Singap. 2005. PMID: 15902345 Free article.

4

Socioeconomic disparities and smoking habits in metabolic syndrome: evidence from isfahan healthy heart program.

Gharipour M, Kelishadi R, Toghianifar N, Tavassoli AA, Khosravi AR, Sajadi F, Sarrafzadegan N. Gharipour M, et al. Among authors: sarrafzadegan n. Iran Red Crescent Med J. 2011 Aug;13(8):537-43. Epub 2011 Aug 1. Iran Red Crescent Med J. 2011. PMID: 22737524 Free PMC article.

5

Pre-hypertension, pre-diabetes or both: which is best at predicting cardiovascular events in the long term?

Khosravi A, Gharipour M, Nezafati P, Khosravi Z, Sadeghi M, Khaledifar A, Taheri M, Golshahi J, Sarrafzadegan N. Khosravi A, et al. Among authors: sarrafzadegan n. J Hum Hypertens. 2017 Jun;31(6):382-387. doi: 10.1038/jhh.2016.42. Epub 2016 Jun 23. J Hum Hypertens. 2017. PMID: 27334522

6

Prevalence of hypertension and associated risk factors in Isfahan, Islamic Republic of Iran.

Sarraf-Zadegan N, Boshtam M, Mostafavi S, Rafiei M. Sarraf-Zadegan N, et al. East Mediterr Health J. 1999 Sep;5(5):992-1001. East Mediterr Health J. 1999. PMID: 10983540 Free article.

7

The Isfahan cohort study: rationale, methods and main findings.

Sarrafzadegan N, Talaei M, Sadeghi M, Kelishadi R, Oveisgharan S, Mohammadifard N, Sajjadieh AR, Kabiri P, Marshall T, Thomas GN, Tavasoli A. Sarrafzadegan N, et al. J Hum Hypertens. 2011 Sep;25(9):545-53. doi: 10.1038/jhh.2010.99. Epub 2010 Nov 25. J Hum Hypertens. 2011. PMID: 21107436

8

Lipid profiles in the Isfahan population: an Isfahan cardiovascular disease risk factor survey, 1994.

Rafiei M, Boshtam M, Sarraf-Zadegan N. Rafiei M, et al. East Mediterr Health J. 1999 Jul;5(4):766-77. East Mediterr Health J. 1999. PMID: 11338699 Free article.

9

Prognostic value of infection and inflammation markers for late cardiac events in an Iranian sample.

Sarrafzadegan N, Rezaporian P, Kaypour M, Mohseni M, Sadeghi M, Asgary S, Sabet B. Sarrafzadegan N, et al. East Mediterr Health J. 2008 Nov-Dec;14(6):1246-56. East Mediterr Health J. 2008. PMID: 19161100 Free article.

10

The relationship between nut consumption and blood pressure in an Iranian adult population: Isfahan Healthy Heart Program.

Yazdekhasti N, Mohammadifard N, Sarrafzadegan N, Mozaffarian D, Nazem M, Taheri M. Yazdekhasti N, et al. Among authors: sarrafzadegan n. Nutr Metab Cardiovasc Dis. 2013 Oct;23(10):929-36. doi: 10.1016/j.numecd.2013.04.014. Epub 2013 Oct 4. Nutr Metab Cardiovasc Dis. 2013. PMID: 24099725

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

549 results

Search Page

Filters